WILLOW LABORATORIES

Lobbying for WILLOW LABORATORIES · technology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · posted Oct 1, 2025

Lobbying activity 2

Health Issues

Support for funding, coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform.

Medicare/Medicaid

Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies; support for CMS TEAM Model [CMMI]

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.